How many studies have been conducted on Rifamycins?

BiohacksAI has indexed 300 PubMed studies on Rifamycins, including 4 randomized controlled trials (RCTs). 27% of studies involve human subjects.

What are the main research areas for Rifamycins?

The primary research domains for Rifamycins are 🫁 Respiratory, 🫁 Liver & Detox, 🛡️ Immunity. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Rifamycins

A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.

300+ PubMed studies analyzed · 4 RCTs · Evidence Score: 45.6

Research Domains

Rifamycins has been studied across 11 research domains including 🫁 Respiratory, 🫁 Liver & Detox, 🛡️ Immunity, 🔬 Oncology, ❤️ Cardiovascular. The primary research focus is 🫁 Respiratory with 7% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rifamycins, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Taurochenodeoxycholic

2 shared targets

Dehydroepiandrosterone

Loading evidence profile...

This evidence profile for Rifamycins is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.